A new strategy that combines the concepts of fragment-based drug design and dynamic combinatorial chemistry (DCC) for targeting adenosine recognition sites on enzymes is reported. We demonstrate the use of 5'-deoxy-5'- thioadenosine as a noncovalent anchor fragment in dynamic combinatorial libraries templated by Mycobacterium tuberculosis pantothenate synthetase. A benzyl disulfide derivative was identified upon library analysis by HPLC. Structural and binding studies of protein-ligand complexes by X-ray crystallography and isothermal titration calorimetry informed the subsequent optimisation of the DCC hit into a disulfide containing the novel meta-nitrobenzyl fragment that targets the pantoate binding site of pantothenate synthetase. Give...
Dynamic combinatorial chemistry (DCC) is a powerful method for the identification of novel ligands f...
We have developed a rigorous computational screening protocol to identify novel fragment-like inhibi...
Fragment-based lead discovery (FBLD) holds great promise for drug discovery, but applications to G p...
A new strategy that combines the concepts of fragment-based drug design and dynamic combinatorial ch...
International audienceMaking new ligands for a given protein by in situ ligation of building blocks ...
SummaryMaking new ligands for a given protein by in situ ligation of building blocks (or fragments) ...
The current work aims to contribute to the proteome research, which means the ultimate characterizat...
We have examined sequence diversity of 147 co-crystal structures of proteins utilizing NAD as a cofa...
Structure-driven fragment-based (SDFB) approaches have provided efficient methods for the identifica...
The requirement for developing antibiotics is continually increasing due to the rise in antibiotic r...
In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challe...
Structure-driven fragment-based (SDFB) approaches have provided efficient methods for the identifica...
Adenine nucleotides are small, abundant molecules that bind numerous proteins involved in pivotal ce...
Proteomics is a powerful approach used for investigating the complex molecular mechanisms of disease...
Fragment-based lead discovery (FBLD) is becoming an increasingly important method in drug developmen...
Dynamic combinatorial chemistry (DCC) is a powerful method for the identification of novel ligands f...
We have developed a rigorous computational screening protocol to identify novel fragment-like inhibi...
Fragment-based lead discovery (FBLD) holds great promise for drug discovery, but applications to G p...
A new strategy that combines the concepts of fragment-based drug design and dynamic combinatorial ch...
International audienceMaking new ligands for a given protein by in situ ligation of building blocks ...
SummaryMaking new ligands for a given protein by in situ ligation of building blocks (or fragments) ...
The current work aims to contribute to the proteome research, which means the ultimate characterizat...
We have examined sequence diversity of 147 co-crystal structures of proteins utilizing NAD as a cofa...
Structure-driven fragment-based (SDFB) approaches have provided efficient methods for the identifica...
The requirement for developing antibiotics is continually increasing due to the rise in antibiotic r...
In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challe...
Structure-driven fragment-based (SDFB) approaches have provided efficient methods for the identifica...
Adenine nucleotides are small, abundant molecules that bind numerous proteins involved in pivotal ce...
Proteomics is a powerful approach used for investigating the complex molecular mechanisms of disease...
Fragment-based lead discovery (FBLD) is becoming an increasingly important method in drug developmen...
Dynamic combinatorial chemistry (DCC) is a powerful method for the identification of novel ligands f...
We have developed a rigorous computational screening protocol to identify novel fragment-like inhibi...
Fragment-based lead discovery (FBLD) holds great promise for drug discovery, but applications to G p...